{"id":140394,"date":"2018-04-09T10:14:38","date_gmt":"2018-04-09T10:14:38","guid":{"rendered":"https:\/\/stg.strategist1trial.com\/o-estudo-strategist-3\/"},"modified":"2025-11-06T16:32:41","modified_gmt":"2025-11-06T16:32:41","slug":"o-estudo-strategist-3","status":"publish","type":"page","link":"https:\/\/stg.strategist3trial.com\/pt-br\/","title":{"rendered":"O estudo StrateGIST 3"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row row_height_percent=&#8221;100&#8243; back_color=&#8221;color-138503&#8243; back_image=&#8221;112255&#8243; back_repeat=&#8221;no-repeat&#8221; back_attachment=&#8221;scroll&#8221; back_position=&#8221;center center&#8221; parallax=&#8221;yes&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider_inv=&#8221;tilt&#8221; shape_bottom_invert=&#8221;yes&#8221; shape_bottom_flip=&#8221;yes&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; shape_bottom_color=&#8221;color-681992&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; el_class=&#8221;gradient&#8221; uncode_shortcode_id=&#8221;821871&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_bottom_color_type=&#8221;uncode-palette&#8221; row_name=&#8221;iphone&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; position_vertical=&#8221;bottom&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; expand_height=&#8221;yes&#8221; style=&#8221;dark&#8221; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;7&#8243; align_mobile=&#8221;align_center_mobile&#8221; mobile_width=&#8221;0&#8243; css_animation=&#8221;bottom-t-top&#8221; animation_delay=&#8221;200&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;177675&#8243; column_width_pixel=&#8221;1000&#8243;][vc_empty_space empty_h=&#8221;5&#8243;][vc_single_image media=&#8221;138429&#8243; media_width_percent=&#8221;36&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;624267&#8243;][vc_column_text text_color=&#8221;color-jevc&#8221; uncode_shortcode_id=&#8221;137548&#8243; text_color_type=&#8221;uncode-palette&#8221;]O IDRX-42 (GSK6042981) \u00e9 um forte inibidor altamente seletivo da prote\u00edna KIT, que \u00e9 hiperativa em muitas pessoas com GIST, o que faz c\u00e9lulas cancerosas crescerem e se acumularem.[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;100&#8243; back_color=&#8221;color-138503&#8243; back_image=&#8221;112267&#8243; back_repeat=&#8221;no-repeat&#8221; back_attachment=&#8221;fixed&#8221; back_position=&#8221;center top&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider_inv=&#8221;tilt&#8221; shape_bottom_invert=&#8221;yes&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; shape_bottom_color=&#8221;color-681992&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; row_name=&#8221;iphone&#8221; el_class=&#8221;gradient&#8221; uncode_shortcode_id=&#8221;159258&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_bottom_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; style=&#8221;dark&#8221; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;7&#8243; align_mobile=&#8221;align_center_mobile&#8221; mobile_width=&#8221;0&#8243; css_animation=&#8221;bottom-t-top&#8221; animation_delay=&#8221;200&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;276875&#8243; column_width_pixel=&#8221;1000&#8243;][vc_empty_space empty_h=&#8221;1&#8243;][vc_single_image media=&#8221;138429&#8243; media_width_percent=&#8221;45&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;927066&#8243;][vc_empty_space empty_h=&#8221;1&#8243;][vc_button button_color=&#8221;color-681992&#8243; border_width=&#8221;0&#8243; uncode_shortcode_id=&#8221;321186&#8243; width=&#8221;216&#8243; link=&#8221;url:%23descricao-do-estudo|title:Perguntas%20frequentes|&#8221; button_color_type=&#8221;uncode-palette&#8221;]Saiba mais[\/vc_button][vc_empty_space empty_h=&#8221;2&#8243;][vc_column_text text_color=&#8221;color-196438&#8243; uncode_shortcode_id=&#8221;111155&#8243; text_color_type=&#8221;uncode-palette&#8221;]Clique aqui para assistir a um v\u00eddeo sobre o StrateGIST 3, incluindo o objetivo do estudo, quem pode entrar no estudo, os medicamentos do estudo e o que esperar durante o estudo.[\/vc_column_text][vc_single_image media=&#8221;123028&#8243; media_width_percent=&#8221;100&#8243; uncode_shortcode_id=&#8221;157773&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;100&#8243; back_color=&#8221;color-138503&#8243; back_image=&#8221;112266&#8243; back_attachment=&#8221;scroll&#8221; back_position=&#8221;center bottom&#8221; parallax=&#8221;yes&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider_inv=&#8221;tilt&#8221; shape_bottom_invert=&#8221;yes&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; shape_bottom_color=&#8221;color-681992&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; medium_visibility=&#8221;yes&#8221; row_name=&#8221;iphone&#8221; el_class=&#8221;gradient&#8221; uncode_shortcode_id=&#8221;204395&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_bottom_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; style=&#8221;dark&#8221; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;7&#8243; align_mobile=&#8221;align_center_mobile&#8221; mobile_width=&#8221;0&#8243; css_animation=&#8221;bottom-t-top&#8221; animation_delay=&#8221;200&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;276875&#8243; column_width_pixel=&#8221;1000&#8243;][vc_empty_space empty_h=&#8221;1&#8243;][vc_single_image media=&#8221;138429&#8243; media_width_percent=&#8221;60&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;482822&#8243;][vc_button button_color=&#8221;color-681992&#8243; border_width=&#8221;0&#8243; uncode_shortcode_id=&#8221;155178&#8243; width=&#8221;216&#8243; link=&#8221;url:%23descricao-do-estudo|title:Perguntas%20frequentes|&#8221; button_color_type=&#8221;uncode-palette&#8221;]Saiba mais[\/vc_button][vc_empty_space empty_h=&#8221;0&#8243;][vc_column_text text_color=&#8221;color-196438&#8243; uncode_shortcode_id=&#8221;111155&#8243; text_color_type=&#8221;uncode-palette&#8221;]Clique aqui para assistir a um v\u00eddeo sobre o StrateGIST 3, incluindo o objetivo do estudo, quem pode entrar no estudo, os medicamentos do estudo e o que esperar durante o estudo.[\/vc_column_text][vc_empty_space empty_h=&#8221;0&#8243;][vc_single_image media=&#8221;123028&#8243; media_width_percent=&#8221;100&#8243; uncode_shortcode_id=&#8221;157773&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;50&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;4&#8243; bottom_padding=&#8221;3&#8243; back_color=&#8221;color-681992&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; bottom_divider=&#8221;tilt&#8221; uncode_shortcode_id=&#8221;168548&#8243; back_color_type=&#8221;uncode-palette&#8221; row_name=&#8221;study-description&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; column_width_pixel=&#8221;1000&#8243; uncode_shortcode_id=&#8221;145453&#8243;][vc_custom_heading text_color=&#8221;color-138503&#8243; heading_semantic=&#8221;h1&#8243; desktop_visibility=&#8221;yes&#8221; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; uncode_shortcode_id=&#8221;671518&#8243; text_color_type=&#8221;uncode-palette&#8221;]<strong>O que \u00e9 o StrateGIST 3?<\/strong>[\/vc_custom_heading][vc_column_text text_color=&#8221;color-xsdn&#8221; uncode_shortcode_id=&#8221;775611&#8243; text_color_type=&#8221;uncode-palette&#8221;]O <span style=\"font-weight: 400;\"><strong style=\"font-size: 20px; color: #ffffff;\">StrateGIST 3<\/strong> \u00e9 um estudo cl\u00ednico que est\u00e1 testando um medicamento experimental chamado IDRX-42 (GSK6042981) em adultos com tumores estromais gastrointestinais (GISTs) metast\u00e1ticos e\/ou irressec\u00e1veis que progrediram ou apresentaram intoler\u00e2ncia \u00e0 terapia de primeira linha com imatinibe.<\/span> <span style=\"font-weight: 400;\">Os pesquisadores querem descobrir mais sobre a seguran\u00e7a do IDRX-42 (GSK6042981) e comparar os efeitos dele com os do sunitinibe, que \u00e9 um tratamento aprovado em alguns pa\u00edses para o tipo de GIST em estudo.<\/span> <span style=\"font-weight: 400;\">Este estudo cl\u00ednico se baseia em achados sobre o IDRX-42 (GSK6042981) de um&nbsp;estudo anterior com pessoas vivendo com GIST.<\/span>[\/vc_column_text][vc_column_text text_color=&#8221;color-xsdn&#8221; uncode_shortcode_id=&#8221;246950&#8243; text_color_type=&#8221;uncode-palette&#8221;]O v\u00eddeo abaixo oferece uma vis\u00e3o geral do StrateGIST 3, incluindo o objetivo do estudo, quem pode entrar no estudo, os medicamentos do estudo e o que esperar durante o estudo.[\/vc_column_text][vc_empty_space empty_h=&#8221;3&#8243;][vc_button button_color=&#8221;color-196438&#8243; border_animation=&#8221;btn-ripple-out&#8221; border_width=&#8221;0&#8243; display=&#8221;inline&#8221; link=&#8221;url:%23localizacao|title:Participe%20do%20estudo|&#8221; button_color_type=&#8221;uncode-palette&#8221; width=&#8221;216&#8243; uncode_shortcode_id=&#8221;132884&#8243;]Encontre um centro de pesquisa[\/vc_button][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;7&#8243; bottom_padding=&#8221;7&#8243; back_color=&#8221;color-138503&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_top_divider=&#8221;default&#8221; top_divider=&#8221;tilt&#8221; shape_top_h_use_pixel=&#8221;&#8221; shape_top_height=&#8221;100&#8243; shape_top_color=&#8221;color-681992&#8243; shape_top_opacity=&#8221;100&#8243; shape_top_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider=&#8221;tilt&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;150&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; uncode_shortcode_id=&#8221;152579&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_top_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; sticky=&#8221;yes&#8221; width=&#8221;1\/2&#8243; uncode_shortcode_id=&#8221;179542&#8243;][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;right&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;242247&#8243;][vc_custom_heading text_size=&#8221;&#8221; uncode_shortcode_id=&#8221;506177&#8243;]<strong>O que acontecer\u00e1 durante o estudo?<\/strong>[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][vc_column_text uncode_shortcode_id=&#8221;183718&#8243;]<span style=\"font-weight: 400\">O estudo testar\u00e1 o medicamento experimental, o IDRX-42, em adultos com GIST metast\u00e1tico e\/ou irressec\u00e1vel que progrediu sob tratamento com imatinibe ou que n\u00e3o toleram os efeitos colaterais do imatinibe. O objetivo \u00e9 comparar os efeitos do IDRX-42 com os do sunitinibe.<\/span><\/p>\n<p><span style=\"font-weight: 400\">O IDRX-42 \u00e9 um medicamento experimental que n\u00e3o foi aprovado por nenhuma autoridade de sa\u00fade para uso fora de estudos cl\u00ednicos.<\/span>[\/vc_column_text][vc_empty_space empty_h=&#8221;4&#8243;][\/vc_column][vc_column column_width_percent=&#8221;95&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; css_animation=&#8221;alpha-anim&#8221; width=&#8221;1\/2&#8243; uncode_shortcode_id=&#8221;900895&#8243;][vc_custom_heading text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;954054&#8243;]Consentimento Livre e Esclarecido[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;195636&#8243;]<span style=\"font-weight: 400\">Antes de voc\u00ea decidir se quer participar, a equipe do estudo analisar\u00e1 os detalhes do estudo com voc\u00ea. Isso incluir\u00e1 poss\u00edveis riscos e benef\u00edcios e o que voc\u00ea poder\u00e1 esperar se decidir participar. Se voc\u00ea decidir participar, pediremos que assine um Termo de Consentimento Livre e Esclarecido. Isso confirmar\u00e1 que voc\u00ea entende o estudo e est\u00e1 disposto(a) a participar para determinar se voc\u00ea \u00e9 eleg\u00edvel.<\/span>[\/vc_column_text][vc_separator sep_color=&#8221;color-prif&#8221; uncode_shortcode_id=&#8221;169390&#8243; sep_color_type=&#8221;uncode-palette&#8221;][vc_custom_heading text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;178847&#8243;]Triagem[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;350149&#8243;]<span style=\"font-weight: 400\">Para verificarmos se voc\u00ea se atende aos crit\u00e9rios de inclus\u00e3o, voc\u00ea comparecer\u00e1 a pelo menos a uma consulta no centro de pesquisa para responder a perguntas sobre sua sa\u00fade e sobre os medicamentos que est\u00e1 tomando e fazer alguns testes\/exames.<\/span>[\/vc_column_text][vc_separator sep_color=&#8221;color-prif&#8221; uncode_shortcode_id=&#8221;169390&#8243; sep_color_type=&#8221;uncode-palette&#8221;][vc_custom_heading text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;209503&#8243;]Tratamento do estudo[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;132873&#8243;]<span style=\"font-weight: 400\">Se voc\u00ea se atender os crit\u00e9rios para inclus\u00e3o do estudo, ser\u00e1 colocado(a) de maneira aleat\u00f3ria em um grupo para receber IDRX-42 ou sunitinibe (o tratamento aprovado).&nbsp;<\/span><\/p>\n<p><span style=\"font-weight: 400\">O IDRX-42 ser\u00e1 fornecido sob a forma de comprimidos tomados oralmente uma vez ao dia em casa. O IDRX-42 \u00e9 tomado todos os dias. O sunitinibe ser\u00e1 tomado por 28 dias consecutivos seguidos de uma pausa de 14 dias (a menos que seu m\u00e9dico d\u00ea instru\u00e7\u00f5es diferentes).&nbsp;<\/span><\/p>\n<p><span style=\"font-weight: 400\">Durante o per\u00edodo de tratamento do estudo, voc\u00ea comparecer\u00e1 ao centro de pesquisa para verificarmos sua sa\u00fade e como seu c\u00e2ncer est\u00e1 respondendo ao tratamento do estudo (IDRX-42 ou sunitinibe).<\/span><\/p>\n<p><span style=\"font-weight: 400\">Se estiver tomando sunitinibe e seu c\u00e2ncer piorar, voc\u00ea talvez possa passar para o IDRX-42.<\/span><\/p>\n<p><strong>O tratamento do estudo (IDRX-42 ou sunitinibe), as consultas do estudo e os testes\/exames relacionados ao estudo ser\u00e3o pagos pelo patrocinador do estudo cl\u00ednico. Reembolso estar\u00e1 dispon\u00edvel para gastos com transporte relacionados \u00e0s consultas do estudo.<\/strong>[\/vc_column_text][vc_separator sep_color=&#8221;color-prif&#8221; uncode_shortcode_id=&#8221;447472&#8243; sep_color_type=&#8221;uncode-palette&#8221;][vc_custom_heading text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;165143&#8243;]Acompanhamento[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;435261&#8243;]<span style=\"font-weight: 400\">Depois que voc\u00ea e seu m\u00e9dico decidirem parar o tratamento do estudo, voc\u00ea comparecer\u00e1 a mais duas consultas e receber\u00e1 telefonemas da equipe do estudo a cada tr\u00eas meses.<\/span>[\/vc_column_text][vc_empty_space empty_h=&#8221;2&#8243;][vc_button button_color=&#8221;color-681992&#8243; border_animation=&#8221;btn-ripple-out&#8221; border_width=&#8221;0&#8243; uncode_shortcode_id=&#8221;626023&#8243; link=&#8221;url:https%3A%2F%2Fstg.strategist1trial.com%2Fpt-br%2Fperguntas-frequentes%2F|title:Perguntas%20frequentes|&#8221; button_color_type=&#8221;uncode-palette&#8221;]Explore as perguntas e respostas do StrateGIST 3[\/vc_button][vc_empty_space empty_h=&#8221;2&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; back_color=&#8221;color-138503&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_top_divider=&#8221;default&#8221; top_divider=&#8221;tilt&#8221; shape_top_h_use_pixel=&#8221;&#8221; shape_top_height=&#8221;100&#8243; shape_top_color=&#8221;color-681992&#8243; shape_top_opacity=&#8221;100&#8243; shape_top_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider=&#8221;tilt&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;150&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; uncode_shortcode_id=&#8221;944839&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_top_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; sticky=&#8221;yes&#8221; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;580905&#8243;][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;right&#8221; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;111259&#8243;][vc_empty_space empty_h=&#8221;3&#8243;][vc_custom_heading text_size=&#8221;&#8221; uncode_shortcode_id=&#8221;506177&#8243;]<strong>O que acontecer\u00e1 durante o estudo?<\/strong>[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;105390&#8243;]<span style=\"font-weight: 400;\">O estudo testar\u00e1 o medicamento experimental, o IDRX-42 (GSK6042981), em adultos com GIST metast\u00e1tico e\/ou irressec\u00e1vel que progrediu sob tratamento com imatinibe ou que n\u00e3o toleram os efeitos colaterais do imatinibe. O objetivo \u00e9 comparar a seguran\u00e7a e os efeitos do IDRX-42 (GSK6042981) com os do sunitinibe.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">O IDRX-42 (GSK6042981) \u00e9 um medicamento experimental que n\u00e3o foi aprovado por nenhuma autoridade de sa\u00fade para uso fora de estudos cl\u00ednicos.<\/span>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;158094&#8243;][vc_custom_heading uncode_shortcode_id=&#8221;175823&#8243;]Sua jornada no StrateGIST 3[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; limit_content=&#8221;&#8221; uncode_shortcode_id=&#8221;663441&#8243;][vc_column_inner column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;1&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;198840&#8243;][vc_single_image media=&#8221;140687&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;359234&#8243;][vc_single_image media=&#8221;140710&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;132086&#8243;][vc_single_image media=&#8221;140733&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;150942&#8243;][vc_single_image media=&#8221;140756&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;161386&#8243;][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; limit_content=&#8221;&#8221; uncode_shortcode_id=&#8221;143909&#8243;][vc_column_inner width=&#8221;1\/1&#8243;][vc_single_image media=&#8221;138549&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;165287&#8243;][vc_single_image media=&#8221;138489&#8243; media_width_percent=&#8221;11&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;197707&#8243;][vc_single_image media=&#8221;138529&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;840834&#8243;][vc_single_image media=&#8221;138489&#8243; media_width_percent=&#8221;11&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;746250&#8243;][vc_single_image media=&#8221;112312&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;108810&#8243;][vc_single_image media=&#8221;138489&#8243; media_width_percent=&#8221;11&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;121070&#8243;][vc_single_image media=&#8221;138509&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;868346&#8243;][\/vc_column_inner][\/vc_row_inner][vc_empty_space empty_h=&#8221;3&#8243;][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;888870&#8243;][vc_button border_width=&#8221;0&#8243; link=&#8221;url:https%3A%2F%2Fstg.strategist1trial.com%2Fpt-br%2Fperguntas-frequentes%2F|title:Perguntas%20frequentes|&#8221; uncode_shortcode_id=&#8221;185672&#8243;]Perguntas frequentes[\/vc_button][vc_empty_space empty_h=&#8221;3&#8243;][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; back_color=&#8221;color-xsdn&#8221; back_image=&#8221;111788&#8243; parallax=&#8221;yes&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_top_divider=&#8221;default&#8221; top_divider=&#8221;tilt&#8221; shape_top_h_use_pixel=&#8221;&#8221; shape_top_height=&#8221;100&#8243; shape_top_opacity=&#8221;100&#8243; shape_top_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider=&#8221;tilt&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; uncode_shortcode_id=&#8221;155709&#8243; back_color_type=&#8221;uncode-palette&#8221; row_name=&#8221;locations&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;881793&#8243; column_width_pixel=&#8221;900&#8243;][vc_empty_space][vc_custom_heading text_size=&#8221;&#8221; uncode_shortcode_id=&#8221;176181&#8243;]<span style=\"font-weight: 400\">Tem interesse em saber mais? <\/span>[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;183639&#8243;]<span style=\"font-weight: 400\">Converse com seu m\u00e9dico para obter mais informa\u00e7\u00f5es e clique no link abaixo para encontrar um centro do estudo StrateGIST 1 perto de voc\u00ea.<\/span>[\/vc_column_text][vc_column_text uncode_shortcode_id=&#8221;654154&#8243;]<b>A participa\u00e7\u00e3o em um estudo cl\u00ednico \u00e9 volunt\u00e1ria, e voc\u00ea poder\u00e1 optar por parar de participar a qualquer momento.<\/b>[\/vc_column_text][vc_empty_space empty_h=&#8221;2&#8243;][vc_button button_color=&#8221;color-773321&#8243; border_animation=&#8221;btn-ripple-out&#8221; border_width=&#8221;0&#8243; uncode_shortcode_id=&#8221;214268&#8243; link=&#8221;url:https%3A%2F%2Fstg.strategisttrials.com%2Ffaqs%2F|title:Perguntas%20frequentes|&#8221; button_color_type=&#8221;uncode-palette&#8221;]Encontre um centro de pesquisa[\/vc_button][vc_empty_space empty_h=&#8221;5&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; uncode_shortcode_id=&#8221;936538&#8243; back_color_type=&#8221;uncode-palette&#8221; row_name=&#8221;location&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;881793&#8243; column_width_pixel=&#8221;900&#8243;][vc_custom_heading text_size=&#8221;&#8221; uncode_shortcode_id=&#8221;118699&#8243;]Tem interesse em saber mais?[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;135948&#8243;]<span style=\"font-weight: 400;\">Fale com seu m\u00e9dico para obter mais informa\u00e7\u00f5es sobre o StrateGIST 3<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Voc\u00ea pode tamb\u00e9m clicar em uma localiza\u00e7\u00e3o no mapa abaixo para encontrar um centro de pesquisa StrateGIST 3 perto de voc\u00ea. O StrateGIST 3 estar\u00e1 dispon\u00edvel em at\u00e9 150 centros de pesquisa no mundo. Novos centros poder\u00e3o abrir. Assim, verifique novamente para ver se houve atualiza\u00e7\u00f5es.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Gastos com transporte relacionados \u00e0s consultas do estudo ser\u00e3o reembolsados<\/span>[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;2&#8243; bottom_padding=&#8221;5&#8243; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; uncode_shortcode_id=&#8221;150898&#8243; back_color_type=&#8221;uncode-palette&#8221;][vc_column width=&#8221;1\/1&#8243;][vc_column_text uncode_shortcode_id=&#8221;326645&#8243;]                <script>\r\n                    const mapStyle = [];\r\n                    const marker_icon = '';\r\n                <\/script>\r\n\t\t\t            <div class=\"store-info-container \">\r\n                <div class=\"store-locations\">\r\n                    <div class=\"store-locations-search OneLinkTx\">\r\n                        <form role=\"search\" class=\"store-search-form\">\r\n                            <label for=\"search-text\"><\/label>\r\n                            <input type=\"text\" value name=\"search-text\" id=\"search-text\"\r\n                                   placeholder=\"Enter a location\">\r\n                            <input type=\"image\" id=\"search-btn\" alt=\"Search\" src=\"https:\/\/stg.strategist3trial.com\/wp-content\/plugins\/jh-wp-site-listing-main\/images\/icon-arrow-right.svg\">\r\n                            <input type=\"hidden\" id=\"place_lat\" value=\"\">\r\n                            <input type=\"hidden\" id=\"place_lng\" value=\"\">\r\n                            <input type=\"hidden\" id=\"show_map\" name=\"show_map\"\r\n                                   value=\"yes\">\r\n\t\t\t\t\t\t\t                            <input type=\"hidden\" id=\"language_code\" value=\"pt-br\">\r\n                        <\/form>\r\n\t\t\t\t\t\t                            <div class=\"my-location\">\r\n                                <a href=\"javascript:void(0);\" onClick=\"getuser_location();\">\r\n\t\t\t\t\t\t\t\t\tUse my Location                                <\/a>\r\n                            <\/div>\r\n\t\t\t\t\t\t                    <\/div>\r\n                    <h5 class=\"store-locations-result-info OneLinkTx\">\r\n\t\t\t\t\t\tShowing                        <span id=\"found-results\"> 0<\/span> Results Near You                    <\/h5>\r\n\t\t\t\t\t                    <div class=\"store-locations-list\" id=\"ajax_results_wrapper\">\r\n                    <\/div>\r\n                <\/div>\r\n\t\t\t\t                    <div class=\"store-map-wrapper\">\r\n                        <div id=\"store-map\">\r\n                        <\/div>\r\n                    <\/div>\r\n\t\t\t\t            <\/div>\r\n\t\t\t[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; uncode_shortcode_id=&#8221;107948&#8243;][vc_column width=&#8221;1\/1&#8243;][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/4&#8243; uncode_shortcode_id=&#8221;136670&#8243;][vc_raw_html]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[\/vc_raw_html][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;961362&#8243; subheading=&#8221;(saiba mais sobre o estudo e concorde em participar)&#8221;]Consentimento Livre e Esclarecido[\/vc_custom_heading][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/4&#8243; uncode_shortcode_id=&#8221;443498&#8243;][vc_raw_html]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[\/vc_raw_html][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;927570&#8243; subheading=&#8221;(veja se voc\u00ea se qualifica)&#8221;]Triagem[\/vc_custom_heading][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/4&#8243; uncode_shortcode_id=&#8221;755785&#8243;][vc_raw_html]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[\/vc_raw_html][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;665102&#8243; subheading=&#8221;IDRX-42 ou sunitinibe&#8221;]Tratamento do estudo[\/vc_custom_heading][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/4&#8243; uncode_shortcode_id=&#8221;127480&#8243;][vc_raw_html]W3Rvb2x0aXBzIGtleXdvcmQgPSAiPGltZyBzcmM9Imh0dHBzOi8vc3RnLnN0cmF0ZWdpc3QxdHJpYWwuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDI0LzExL0FnZS5wbmciLz4iIGNvbnRlbnQgPSAiPGgyPkFjb21wYW5oYW1lbnRvPC9oMj48ZGl2PjxoNj5EZXBvaXMgcXVlIHZvY8OqIGUgc2V1IG3DqWRpY28gZGVjaWRpcmVtIHBhcmFyIG8gdHJhdGFtZW50byBkbyBlc3R1ZG8sIHZvY8OqIGNvbXBhcmVjZXLDoSBhIG1haXMgZHVhcyBjb25zdWx0YXMgZSByZWNlYmVyw6EgdGVsZWZvbmVtYXMgZGEgZXF1aXBlIGRvIGVzdHVkbyBhIGNhZGEgdHLDqnMgbWVzZXMuPC9oNj48YnI+PGJyPjwvZGl2PiJd[\/vc_raw_html][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;152286&#8243;]Acompanhamento[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row row_height_percent=&#8221;100&#8243; back_color=&#8221;color-138503&#8243; back_image=&#8221;112255&#8243; back_repeat=&#8221;no-repeat&#8221; back_attachment=&#8221;scroll&#8221; back_position=&#8221;center center&#8221; parallax=&#8221;yes&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider_inv=&#8221;tilt&#8221; shape_bottom_invert=&#8221;yes&#8221; shape_bottom_flip=&#8221;yes&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-140394","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/stg.strategist3trial.com\/pt-br\/wp-json\/wp\/v2\/pages\/140394","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stg.strategist3trial.com\/pt-br\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/stg.strategist3trial.com\/pt-br\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/stg.strategist3trial.com\/pt-br\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/stg.strategist3trial.com\/pt-br\/wp-json\/wp\/v2\/comments?post=140394"}],"version-history":[{"count":0,"href":"https:\/\/stg.strategist3trial.com\/pt-br\/wp-json\/wp\/v2\/pages\/140394\/revisions"}],"wp:attachment":[{"href":"https:\/\/stg.strategist3trial.com\/pt-br\/wp-json\/wp\/v2\/media?parent=140394"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}